AUA2021 May Kick-Off Weekend Webcast Series (2021)
The AUA2021 May Kick-off Weekend will be held virtually from May 21 through 23. Offered as an exclusive benefit to AUA2021 registrants, the three-day program will provide over 35 hours of live educational content. Access to the Summer School Kick-off Weekend live webinars are included in ALL AUA2021 Meeting packages and will have On-demand webcasts following the live event.
FOLLOWING MAY KICK-OFF WEEKEND, SELECT COURSE WEBCASTS WILL BE RELEASED FOR CME!
SEE FULL SCHEDULE BELOW:
Webcast |
---|
Incorporating Genomic Testing for Prostate Cancer into Your Practice |
Contemporary Pharmacotherapy for OAB 2021: Monotherapy & Combined Pharmacotherapy to Optimize Treatment |
Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider |
Trimodality Therapy for Management of Muscle Invasive Bladder Cancer |
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer |
Target Audience
- Urologists
- Residents
- Advanced Practice Providers (Nurse Practitioners and Physician Assistants)
Contemporary Pharmacotherapy for OAB 2021: Monotherapy and Combined Pharmacotherapy to Optimize Treatment
Course Director: Eric Scott Rovner, MD
Course Faculty: Christopher R. Chapple, MD; Alan J. Wein, MD, PhD
Trimodality Therapy for Management of Muscle Invasive Bladder Cancer
Course Director: Adam S. Feldman, MD, MPH
Course Faculty: Jason Efstathiou, MD, PhD; Richard J. Lee, MD, PhD
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer
Course Director: W. Marston Linehan, MD
Course Faculty: Mark W. Ball, MD; Ramaprasad Srinivasan, MD, PhD; David F. McDermott, MD
Chemotherapy and Immunotherapy for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers
Course Director: Costas D. Lallas, MD
Course Faculty: Anne E. Calvaresi, NP; Edouard J. Trabulsi, MD
Incorporating Genomic Testing for Prostate Cancer into Your Practice
Course Director: Joseph Wagner, MD
Course Faculty: Matthew Cooperberg, MD, MPH; Daniel Lin, MD
Education Council Disclosures
Education Council Disclosures 2021
COI Review Work Group Disclosures
COI Review Work Group Disclosures 2021
All relevant financial relationships have been mitigated.
AUA Office of Education Staff has nothing to disclose.
METHOD OF PARTICIPATION:
Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.
Estimated time to complete this activity: 10.00 hours
Release Date: May, 2021
Expiration Date: March, 2022
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this enduring material for a maximum of 10.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.